Rose Kim Chang Hull, NP

Rose Chang Hull practices at Rapid Care - Adventist Health Physicians Network (W Lacey Blvd) in Hanford, California.

Rose Chang Hull's NPI, 1174811046, was assigned on July 13, 2011. Rose Chang Hull holds California license NP20843.

Rose Chang Hull's primary practice is Rapid Care - Adventist Health Physicians Network (W Lacey Blvd), at 1524 W Lacey Blvd, Hanford, CA 93230. The practice phone is (559) 583-4695.

Rose Chang Hull's primary practice is Rapid Care - Adventist Health Physicians Network (W Lacey Blvd) in Hanford, California. Rose Chang Hull is also affiliated with Adventist Health Hanford. The medical group on file is Adventist Health Physicians Network. Dmand AI also links Rose Chang Hull to 1 more group practice or clinic and 1 home health agency, each named with a free account. Rose Chang Hull's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Rose Chang Hull practices, 4 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Rose Chang Hull's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Rose Chang Hull is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, adjustment disease, alcohol use disorders, alzheimer's disease, anxiety, arthritis and asthma among the conditions Rose Chang Hull treats.

CMS data shows 745 Medicare services from Rose Chang Hull across 8 procedure codes in 2024, for 194 Medicare patients. Medicare paid $46,630 for them. Every service was in an office.

CMS counts 194 Medicare patients who saw Rose Chang Hull in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Rose Chang Hull's median patient age at 62, with 81% women.

In 2024, Rose Chang Hull wrote 4,162 Medicare Part D claims for 362 patients. 90% of them were for generic drugs. CMS names the drug for 3,499 of them, across 77 drugs with 11 or more claims each, at $173,260 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Rose Chang Hull for performance year 2024, reported through an alternative payment model (APM). Rose Chang Hull accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rose Chang Hull as offering telehealth.

CMS Open Payments shows 27 general payments to Rose Chang Hull from 6 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $260.